Researchers are currently investigating new treatments for recurrent breast cancer. Participation in trials of these treatments will lead to improved therapies. If you wish to participate in a clinical trial, please talk to your doctor about the potential benefits and side effects of the treatment.
The following are areas of active study aimed at improving the treatment of recurrent breast cancer.- New targeted therapies, including epidermal growth factor receptors (EGFRs), such as Tarceva® (erlotinib)
- Advances in chemotherapy, such as Camptosar® (irinotecan)
- Photodynamic therapy (use of a chemical that destroys only cancer cells when they are exposed to a certain type of light)
No comments:
Post a Comment